albuterol has been researched along with Acidosis, Respiratory in 6 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Acidosis, Respiratory: Respiratory retention of carbon dioxide. It may be chronic or acute.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Initial severe acidosis consisted of acute respiratory acidosis from ventilation-perfusion mismatch and acute metabolic acidosis resulting from bronchospasm and hypoxia-related lactic acidosis, respectively." | 8.02 | Salbutamol-induced lactic acidosis in status asthmaticus survivor. ( Boonkaya, S; Phoophiboon, V; Singhagowinta, P; Sriprasart, T, 2021) |
| " Initial severe acidosis consisted of acute respiratory acidosis from ventilation-perfusion mismatch and acute metabolic acidosis resulting from bronchospasm and hypoxia-related lactic acidosis, respectively." | 4.02 | Salbutamol-induced lactic acidosis in status asthmaticus survivor. ( Boonkaya, S; Phoophiboon, V; Singhagowinta, P; Sriprasart, T, 2021) |
| "Acute exacerbations of chronic obstructive pulmonary disease (COPD)--characterized by shortness of breath, increased sputum production, increased purulence, or a combination of these signs--are costly and can have major impacts on the patient's health." | 2.53 | Treating and preventing acute exacerbations of COPD. ( Aboussouan, LS; Hatipoglu, US, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Phoophiboon, V | 1 |
| Singhagowinta, P | 1 |
| Boonkaya, S | 1 |
| Sriprasart, T | 1 |
| Cancado, JE | 1 |
| Mendes, ES | 1 |
| Arana, J | 1 |
| Horvath, G | 1 |
| Monzon, ME | 1 |
| Salathe, M | 1 |
| Wanner, A | 1 |
| Hatipoglu, US | 1 |
| Aboussouan, LS | 1 |
| Mazzeo, AT | 1 |
| Spada, A | 1 |
| Praticò, C | 1 |
| Lucanto, T | 1 |
| Santamaria, LB | 1 |
| Haddad, S | 1 |
| Arabi, Y | 1 |
| Shimemeri, AA | 1 |
| Anderson, SD | 1 |
| Silverman, M | 1 |
| König, P | 1 |
| Godfrey, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Evidence of pH Dependent ß2 Adrenergic Transport Mechanisms in the Airway[NCT01216748] | 10 participants (Actual) | Interventional | 2010-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Effect of airway pH on albuterol responsiveness as reflected by the change in airway blood flow after 180μg albuterol by inhalation (ΔQaw) vs baseline. (NCT01216748)
Timeframe: 15 minutes after albuterol inhalation
| Intervention | changes from baseline in μl.min-1.ml-1 (Mean) | |||
|---|---|---|---|---|
| quiet breathing | eucapnic hyperventilation | hypocapnic hyperventilation | hypercapnic hyperventilation | |
| Health Controls | 16.8 | 14.5 | -0.2 | 2.0 |
"EBC samples were collected at each respiratory maneuver by directing the subject's exhaled breath into a pre-cooled (-10C) tube for 10 min.~pH was measured immediately after collection." (NCT01216748)
Timeframe: 10 minutes after each respiratory manouver.
| Intervention | pH (Mean) | |||
|---|---|---|---|---|
| quiet breathing | hypocapnic hyperventilation | hypercapnic hyperventilation | eucapnic hyperventilation | |
| Health Controls | 6.39 | 6.31 | 6.59 | 5.88 |
1 review available for albuterol and Acidosis, Respiratory
| Article | Year |
|---|---|
Treating and preventing acute exacerbations of COPD.
Topics: Acidosis, Respiratory; Acute Disease; Administration, Inhalation; Albuterol; Anti-Bacterial Agents; | 2016 |
1 trial available for albuterol and Acidosis, Respiratory
| Article | Year |
|---|---|
Effect of airway acidosis and alkalosis on airway vascular smooth muscle responsiveness to albuterol.
Topics: Acidosis, Respiratory; Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adult; Albut | 2015 |
4 other studies available for albuterol and Acidosis, Respiratory
| Article | Year |
|---|---|
Salbutamol-induced lactic acidosis in status asthmaticus survivor.
Topics: Acidosis; Acidosis, Lactic; Acidosis, Respiratory; Adrenergic beta-2 Receptor Agonists; Adult; Albut | 2021 |
Hypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach.
Topics: Acidosis, Respiratory; Albuterol; Asthma; Bronchodilator Agents; Child; Drug Therapy, Combination; G | 2004 |
Hypokalemic paralysis mimicking Guillain-Barré syndrome and causing acute respiratory failure.
Topics: Acidosis, Respiratory; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Blood Gas Analysis; Diagn | 2004 |
Exercise-induced asthma.
Topics: Acidosis, Respiratory; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Airway Obstruction; Air | 1975 |